A modified IL-18 drug in combination with CTLA-4 blockade enhances anti-tumor efficacy in preclinical models of renal cell carcinoma

被引：0
|
作者：
Schoenfeld, David [1 ]
Djureinovic, Dijana [1 ]
Zhang, Lin [1 ]
Mann, Jacqueline [1 ]
Huck, John [2 ]
Jilaveanu, Lucia [1 ]
Ring, Aaron [2 ]
Kluger, Harriet [1 ]
机构：
[1] Yale Sch Med, Sect Med Oncol, New Haven, CT USA
[2] Yale Sch Med, Dept Immunobiol, New Haven, CT USA
来源：
ONCOLOGIST | 2023年 / 28卷
关键词：
IL-18; cytokines; immune-checkpoint inhibitors; anti-CTLA-4; preclinical models; RCC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
58
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [31] Nonclinical evaluation of the combination of mouse IL-21 and anti- mouse CTLA-4 or PD-1 blocking antibodies in mouse tumor models
    Jure-Kunkel, Maria
    Selby, Mark
    Lewis, Katherine
    Masters, Gregg
    Valle, Jose
    Grosso, Joseph
    Dito, Gennaro
    Curtis, Wendy
    Garcia, Richard
    Holdren, Matthew
    Korman, Alan J.
    Dillon, Stacey
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [32] Preclinical anti-tumor efficacy of an anti-C4.4a (LYPD3) antibody drug conjugate for the treatment of lung squamous cell carcinoma
    Willuda, Joerg
    Linden, Lars
    Lerchen, Hans-Georg
    Kopitz, Charlotte
    Golfier, Sven
    Bach, Ute
    Schumacher, Joachim
    Stelte-Ludwig, Beatrix
    Von Ahsen, Oliver
    Schneider, Claudia
    Dittmer, Frank
    Beier, Rudolf
    El-Sheik, Sherif
    Tebbe, Jan
    Leder, Gabriele
    Apeler, Heiner
    Jautelat, Rolf
    Kreft, Bertolt
    Ziegelbauer, Karl
    CANCER RESEARCH, 2014, 74 (19)
  • [33] Anti-tumor efficacy of the selective pan-FGFR Inhibitor BAY 1163877 in preclinical squamous cell carcinoma models of different origin
    Heroult, Melanie
    Ocker, Matthias
    Kopitz, Charlotte
    Zopf, Dieter
    Haegebarth, Andrea
    Ziegelbauer, Karl
    Ince, Stuart
    Ellinghaus, Peter
    CANCER RESEARCH, 2015, 75
  • [34] Dll4 Blockade Potentiates the Anti-Tumor Effects of VEGF Inhibition in Renal Cell Carcinoma Patient-Derived Xenografts
    Miles, Kiersten Marie
    Seshadri, Mukund
    Ciamporcero, Eric
    Adelaiye, Remi
    Gillard, Bryan
    Sotomayor, Paula
    Attwood, Kristopher
    Shen, Li
    Conroy, Dylan
    Kuhnert, Frank
    Lalani, Alshad S.
    Thurston, Gavin
    Pili, Roberto
    PLOS ONE, 2014, 9 (11):
  • [35] CD40 agonism improves anti-tumor T cell priming induced by the combination of radiation therapy plus CTLA4 inhibition and enhances tumor response
    Charpentier, Maud
    Formenti, Silvia
    Demaria, Sandra
    ONCOIMMUNOLOGY, 2023, 12 (01):
  • [36] A novel small molecule inhibitor of ENPP1 promotes T and NK cell activation and enhances anti-tumor efficacy in combination with immune checkpoint blockade therapy
    Yoon, Pyoung Oh
    Kim, Juhyeon
    Lee, A-Ram
    Son, Eunji
    Lee, Young Cheol
    Jung, Eunmi
    Kim, HyeongRae
    Lee, YeonHee
    Park, Soeun
    Lee, Dae-Yon
    Chung, Chul-Woong
    CANCER RESEARCH, 2023, 83 (07)
  • [37] Combination gene therapy with IL-12 and IFN-α induces a synergistic anti-tumor response against established colon and renal cell carcinoma
    Mendiratta, SK
    Quezada, A
    Matar, M
    Thull, NM
    Bishop, JS
    Nordstrom, JL
    Pericle, F
    CANCER GENE THERAPY, 2000, 7 (12) : S23 - S23
  • [38] Synergistic Anti-Tumor Efficacy of BET Inhibitors JQ1 and Otx-015 in Combination with Dasatinib in Preclinical Models of T-Cell Lymphomas
    Rizzitano, Sara
    Cavane, Alessandra
    Piazzoni, Marco
    Vendramin, Antonio
    Gimondi, Silvia
    Biancon, Giulia
    Malan, Sofia Cannara
    Dodero, Anna
    Corradini, Paolo
    Carniti, Cristiana
    BLOOD, 2016, 128 (22)
  • [39] INK128, a potent and selective TORC1/2 inhibitor, demonstrates anti-tumor activity in preclinical models of renal cell carcinoma by a distinct mechanism
    Liu, Y.
    Jessen, K.
    Wang, S.
    Kessler, L.
    Li, L.
    Darjania, L.
    Martin, M.
    Ren, P.
    Klein, P.
    Rommel, C.
    EJC SUPPLEMENTS, 2010, 8 (07): : 154 - 155
  • [40] The effect of immunotherapy based on a combination of modified dendritic cells overproducing IL-12, IL-15 or IL-18 and anti-IL-10R antibodies on the inhibition of tumor growth in MC38 colon carcinoma
    Ciura, Katarzyna Wegierek
    Mierzejewska, Jagoda
    Szczygiel, Agnieszka
    Wroblewska, Anna
    Olearnik, Bozena Szermer
    Rossowska, Joanna
    Piasecka, Elzbieta Pajtasz
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 407 - 407
12345